in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (4 weeks ago)
Read our latest #SaferWorldbydesign newsletter highlighting SaferSkin™ new features and products. #SaferSkin… https://t.co/z9SmrlJ3Yb
Edelweiss Connect (4 weeks ago)
Curation of drug-induced mechanistic toxicological processes and adverse outcome pathway in (DILI) Presented by Cu… https://t.co/8n0QoR3gXa
Edelweiss Connect (4 weeks ago)
The approach may be further extended by additional in silico and in vitro methods to strengthen the weight of evide… https://t.co/oLCdYGMTnW
Edelweiss Connect (4 weeks ago)
Our #SaferSkin™ app implements three well-adopted approaches to perform an integrated analysis of the OECD-approved… https://t.co/MA7DY0RdwO
Edelweiss Connect (6 weeks ago)
#SaferWorldbyDesign & @MultiCASEInc present: Use of in silico methods for assessing toxicity #QSAR #insilico… https://t.co/AgoolrhT7M

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA